Author

Marcos Romário Matos de Souza

Stony Brook UniversityORCID 0000-0002-9365-3224Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Amílcar TanuriiD· 1 shared Anna Beatriz Sampaio Vianna Macedo Pimentel· 1 shared Débora Souza FaffeiD· 1 shared Diana MarianiiD· 1 shared Elena E. Gorbunova· 1 shared Elisa Cavalcante PereiraiD· 1 shared Erich R. MackowiD· 1 shared Grace E. HimmleriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Amílcar TanuriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintMar 27, 2026

Powassan Virus LB Neurovirulence and Lethality is Determined by Envelope Protein Domain III Residues

Marissa R. Lindner, Elena E. Gorbunova, Marcos Romário Matos de Souza…·Erich R. Mackow

This study identifies specific envelope protein domain III residues that determine neurovirulence and lethality of Powassan Virus lineage I, showing that mutations can attenuate the virus and elicit protective immunity.

DOI 10.64898/2026.03.26.714546

mouseexperimental assay

𝕏 PostBluesky

MicrobiologyFrontiers in Cellular and Infection MicrobiologyPeer-reviewedJul 11, 2025

Unique RNA replication characteristics and nucleocapsid protein expression may explain differences in the replication capacity of SARS-COV-2 lineages.

Isadora Alonso Corrêa, Marcos Romário Matos de Souza, Gustavo Peixoto Duarte da Silva…·Luciana Jesus da Costa

This study compares replication capacity and nucleocapsid proteoforms across SARS-CoV-2 variants in human pulmonary cells, finding Omicron BA.1 has reduced replication and variant-specific proteoforms.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky